Toradol (ketorolac) is often perceived as much stronger than ibuprofen, but head-to-head studies consistently show the two drugs provide comparable pain relief. The real difference isn’t potency per milligram. It’s how ketorolac is given, how fast it works, and the trade-offs that come with it.
How They Compare for Pain Relief
In a randomized clinical trial of post-surgical patients, 30 mg of IV ketorolac and 800 mg of ibuprofen produced nearly identical pain scores, both at rest and while moving. Patients in the ketorolac group also used roughly the same amount of additional opioid painkillers as those in the ibuprofen group, suggesting neither drug left patients needing more backup relief than the other.
For acute back pain in the emergency department, a separate study compared a standard 400 mg oral ibuprofen dose to a 10 mg intramuscular ketorolac injection. After one hour, pain reduction was virtually the same: a 35-point drop on the pain scale for ibuprofen versus 32 for ketorolac. The researchers found no meaningful difference.
One exception showed up in patients recovering from major abdominal surgery. In that subgroup, ketorolac did produce significantly lower pain scores at rest and higher patient satisfaction. So for more invasive procedures, ketorolac may have a slight edge, but for the broad range of moderate to severe pain, the two drugs perform similarly.
Why Toradol Feels Stronger
If ketorolac isn’t dramatically more potent, why does it seem so powerful when you get it in the ER? The answer is mostly about delivery. Ketorolac given through an IV or as an injection enters your bloodstream immediately, bypassing the digestive system entirely. That means it starts working in minutes rather than the 30 to 60 minutes a swallowed ibuprofen tablet needs to dissolve and absorb. The oral form of ketorolac reaches peak blood levels in about 44 minutes, with peak pain relief arriving within 2 to 3 hours.
There’s also a psychological component. Receiving an injection or IV in a clinical setting primes you to expect stronger medicine, and that expectation itself can amplify the perceived effect. When researchers control for this by giving one group a placebo injection alongside oral ibuprofen and the other group a placebo pill alongside injected ketorolac, the gap between the two drugs essentially disappears.
They Work the Same Way, With One Key Difference
Both ketorolac and ibuprofen are NSAIDs. They reduce pain and inflammation by blocking enzymes called COX-1 and COX-2, which your body uses to produce compounds that trigger swelling and pain signaling. The difference is in selectivity. Ketorolac is roughly six times more active against COX-1 than COX-2. This makes it the most COX-1 selective of all common NSAIDs.
That selectivity matters because COX-1 plays a protective role in your stomach lining, kidneys, and blood clotting. Blocking it aggressively means ketorolac is effective at reducing pain but also carries a higher risk of side effects in those areas.
Ketorolac Carries Higher Risks
The most important practical difference between these two drugs isn’t strength. It’s safety. A meta-analysis of 28 studies found that ketorolac’s relative risk of gastrointestinal side effects was 11.5, compared to just 1.84 for ibuprofen. In plain terms, ketorolac is associated with a dramatically higher rate of stomach bleeding, ulcers, and intestinal perforation. These events can happen without warning symptoms.
Ketorolac also poses greater risks to kidney function. Reports of acute kidney failure, inflammation of kidney tissue, and related conditions have been documented. It inhibits platelet function more aggressively than ibuprofen, meaning it interferes with blood clotting and is contraindicated for anyone at high risk of bleeding or who has had a recent stroke involving brain bleeding.
These risks are why the FDA limits ketorolac to a maximum of five days of use, total, across all forms (oral, IV, or injection combined). Exceeding five days doesn’t improve pain relief but significantly increases the chance of serious complications. Side effects also climb in patients over 75. Ibuprofen, by contrast, can be used for weeks or longer under medical guidance, though it carries its own risks with prolonged use.
When Each Drug Makes Sense
Ketorolac is a short-term, clinical tool. It’s typically reserved for situations where you need fast-acting, non-opioid pain relief and someone can administer it by injection or IV: post-surgical recovery, emergency department visits for kidney stones or severe acute pain, or the first day or two after a procedure. Its speed of onset and injectable route make it practical in settings where swallowing a pill isn’t ideal.
Ibuprofen is the everyday workhorse. It’s available over the counter, comes in multiple forms, and can be used safely for longer periods. For headaches, menstrual cramps, muscle strains, dental pain, and most other common pain scenarios, ibuprofen provides the same level of relief without the heightened risk profile. If you’ve ever wondered whether the Toradol shot you got in the ER was “the strong stuff” compared to the ibuprofen you take at home, the honest answer is that milligram for milligram ketorolac is more concentrated, but the actual pain relief at standard doses is remarkably similar. What you’re really getting with ketorolac is faster delivery, not a fundamentally different level of pain control.